These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31384431)

  • 21. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China.
    Huang J; Li M; Tian Z; Hsieh E; Wang Q; Liu Y; Xu D; Hou Y; Zhao J; Guo X; Lai J; Hu C; Song N; Sun Q; Sun Q; Zhang F; Zhao Y; Zeng X
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-115-21. PubMed ID: 25372797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.
    Methia N; Latreche S; Ait Mokhtar O; Monsuez JJ; Benkhedda S
    Am J Med Sci; 2016 Oct; 352(4):343-347. PubMed ID: 27776714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.
    Kelemen BW; Mathai SC; Tedford RJ; Damico RL; Corona-Villalobos C; Kolb TM; Chaisson NF; Harris TH; Zimmerman SL; Kamel IR; Kass DA; Hassoun PM
    Pulm Circ; 2015 Jun; 5(2):327-34. PubMed ID: 26064458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.
    Nagaya N; Uematsu M; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Yamagishi M; Kunieda T; Miyatake K
    Am J Respir Crit Care Med; 1999 Aug; 160(2):487-92. PubMed ID: 10430718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
    Hachulla E; Gressin V; Guillevin L; Carpentier P; Diot E; Sibilia J; Kahan A; Cabane J; Francès C; Launay D; Mouthon L; Allanore Y; Tiev KP; Clerson P; de Groote P; Humbert M
    Arthritis Rheum; 2005 Dec; 52(12):3792-800. PubMed ID: 16320330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH).
    Petrow E; Feng C; Frazer-Abel A; Marangoni RG; Lutz K; Nichols WC; Holers VM; Ritchlin C; White RJ; Korman BD
    Semin Arthritis Rheum; 2024 Dec; 69():152554. PubMed ID: 39298973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Three Different Algorithms for the Screening of SSc-PAH and Comparison with the Decisions of a Multidisciplinary Team.
    Coirier V; Chabanne C; Jouneau S; Belhomme N; Ballerie A; Cazalets C; Sobanski V; Hachulla É; Jégo P; Lescoat A
    Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum uric acid as a marker of microvascular damage in systemic sclerosis patients.
    Gigante A; Barbano B; Barilaro G; Quarta S; Gasperini ML; Di Mario F; Romaniello A; Amoroso A; Cianci R; Rosato E
    Microvasc Res; 2016 Jul; 106():39-43. PubMed ID: 27003713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc).
    Jiang Y; Turk MA; Pope JE
    Autoimmun Rev; 2020 Sep; 19(9):102602. PubMed ID: 32659476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
    Weatherald J; Boucly A; Launay D; Cottin V; Prévot G; Bourlier D; Dauphin C; Chaouat A; Savale L; Jaïs X; Jevnikar M; Traclet J; De Groote P; Simonneau G; Hachulla E; Mouthon L; Montani D; Humbert M; Sitbon O
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30209196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.
    Li M; Pan W; Tian D; Chen D; Zhang X; Zhang Y; Chen S; Zhou D; Ge J
    Curr Vasc Pharmacol; 2024; 22(1):67-77. PubMed ID: 38038005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.